Empery Asset Management, LP
13F Reported Value
ⓘ$83.0M
Holdings
32
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Empery Asset Management, LP disclosed 32 positions worth $83.0M in its Form 13F-HR for Q1 2026, led by $XFOR (X4 Pharmaceuticals, Inc) at 44.5% of the equity portfolio, followed by $EMPD and $DTIL. During the quarter the fund opened 12 new positions and exited 11 — including a new stake in $VENU and a full exit from $IMRX. The portfolio is most concentrated in Healthcare (66.9% of disclosed assets). All figures are sourced directly from Empery Asset Management, LP’s Form 13F-HR filing with the SEC under CIK 1469336.
Sector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 29.3#2,415
Quality
$36.9M8,944,118 sh - 7.8#2,830
Quality
$12.4M2,930,345 sh - 3.9#2,856
Quality
$10.8M1,968,879 sh IMPERIAL PETE INC
—Quality
$3.8M877,645 sh- 11.2
Quality
$3.3M1,007,729 sh - —
Quality
$3.0M4,286,933 sh U S ENERGY CORP DEL
—Quality
$1.7M1,917,844 sh- —
Quality
$1.7M1,847,826 sh - —
Quality
$1.6M957,784 sh - —
Quality
$1.3M487,500 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 X4 Pharmaceuticals, Inc$XFOR | 29.3#2,415 | $36.9M | 8,944,118 |
 Empery Digital Inc.$EMPD | 7.8#2,830 | $12.4M | 2,930,345 |
 PRECISION BIOSCIENCES INC$DTIL | 3.9#2,856 | $10.8M | 1,968,879 |
| IMPERIAL PETE INC | — | $3.8M | 877,645 |
 Venu Holding Corp$VENU | 11.2 | $3.3M | 1,007,729 |
 Tenaya Therapeutics, Inc.$TNYA | — | $3.0M | 4,286,933 |
| U S ENERGY CORP DEL | — | $1.7M | 1,917,844 |
 SCYNEXIS INC$SCYX | — | $1.7M | 1,847,826 |
 Cyngn Inc.$CYN | — | $1.6M | 957,784 |
 Jaguar Uranium Corp.$JAGU | — | $1.3M | 487,500 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Empery Asset Management, LP's 32 positions.
Showing top 10 of 32 holdings.
Sector Allocation
Healthcare
$55.6M
Industrials
$12.6M
Other
$5.8M
Communication Services
$3.3M
Materials
$3.3M
Technology
$2.1M
Financials
$289,057
Consumer Staples
$15,300
Full Holdings — Empery Asset Management, LP (Q1 2026)
All 32 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $XFOR | X4 Pharmaceuticals, Inc | $36.9M | 44.5% | -0% | 29.3 |
| 2 | $EMPD | Empery Digital Inc. | $12.4M | 14.9% | +0% | 7.8 |
| 3 | $DTIL | PRECISION BIOSCIENCES INC | $10.8M | 13.0% | -10% | 3.9 |
| 4 | — | IMPERIAL PETE INC | $3.8M | 4.5% | -72% | — |
| 5 | $VENU | Venu Holding Corp | $3.3M | 4.0% | NEW | 11.2 |
| 6 | $TNYA | Tenaya Therapeutics, Inc. | $3.0M | 3.6% | -21% | — |
| 7 | — | U S ENERGY CORP DEL | $1.7M | 2.0% | NEW | — |
| 8 | $SCYX | SCYNEXIS INC | $1.7M | 2.0% | NEW | — |
| 9 | $CYN | Cyngn Inc. | $1.6M | 1.9% | NEW | — |
| 10 | $JAGU | Jaguar Uranium Corp. | $1.3M | 1.6% | NEW | — |
| 11 |  $MSLE | Satellos Bioscience Inc. | $1.3M | 1.6% | NEW | — |
| 12 |  $CRML | Critical Metals Corp. | $1.0M | 1.3% | -73% | — |
| 13 |  $URG | UR-ENERGY INC | $924,003 | 1.1% | NEW | 24.1 |
| 14 |  $PMN | ProMIS Neurosciences Inc. | $766,483 | 0.9% | NEW | — |
| 15 |  $SLE | Super League Enterprise, Inc. | $491,793 | 0.6% | -89% | — |
| 16 |  $TLPH | TALPHERA, INC. | $441,030 | 0.5% | -56% | — |
| 17 |  $BNTC | Benitec Biopharma Inc. | $324,186 | 0.4% | -45% | — |
| 18 | — | BRIACELL THERAPEUTICS CORP | $309,030 | 0.4% | NEW | — |
| 19 |  $ABTS | Abits Group Inc | $266,052 | 0.3% | NEW | — |
| 20 |  $PRZO | ParaZero Technologies Ltd. | $217,575 | 0.3% | NEW | — |
| 21 |  $NSRX | Nasus Pharma Ltd | $101,683 | 0.1% | NEW | — |
| 22 |  $BCTX | BriaCell Therapeutics Corp. | $93,324 | 0.1% | +0% | — |
| 23 |  $NTRB | NutriBand Inc. | $45,044 | 0.1% | +0% | — |
| 24 |  $MTEK | Maris Tech Ltd. | $44,938 | 0.1% | +0% | — |
| 25 |  $RTAC | Renatus Tactical Acquisition Corp I | $23,005 | 0.0% | +0% | — |
| 26 |  $NRSN | NeuroSense Therapeutics Ltd. | $20,080 | 0.0% | +0% | — |
| 27 |  $MDAI | Spectral AI, Inc. | $18,665 | 0.0% | +0% | — |
| 28 |  $BNC | CEA Industries Inc. | $15,300 | 0.0% | +0% | 64.9 |
| 29 |  $MDCX | Medicus Pharma Ltd. | $11,494 | 0.0% | +0% | — |
| 30 |  $NEXR | Nexera Technologies Ltd | $6,130 | 0.0% | +0% | — |
| 31 |  $NXGL | NEXGEL, INC. | $5,391 | 0.0% | +0% | — |
| 32 |  $FGI | FGI Industries Ltd. | $2,694 | 0.0% | +0% | — |
New Positions (12)
$VENU Venu Holding Corp$3.3M$SCYX SCYNEXIS INC$1.7M$CYN Cyngn Inc.$1.6M$JAGU Jaguar Uranium Corp.$1.3M$MSLE Satellos Bioscience Inc.$1.3M$URG UR-ENERGY INC$924,003$PMN ProMIS Neurosciences Inc.$766,483$ABTS Abits Group Inc$266,052$PRZO ParaZero Technologies Ltd.$217,575$NSRX Nasus Pharma Ltd$101,683Exited Positions (11)
$IMRX Immuneering Corp
$ADUR ADURO CLEAN TECHNOLOGIES INC.
$EOSE Eos Energy Enterprises, Inc.
$SRZN Surrozen, Inc./DE
$KZIA KAZIA THERAPEUTICS LTD
$PROF Profound Medical Corp.
$RBNE Robin Energy Ltd.
$XLO Xilio Therapeutics, Inc.
$ALUR-WT ALLURION TECHNOLOGIES, INC.
$TARA Protara Therapeutics, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Empery Asset Management, LP including:
Track Empery Asset Management, LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Empery Asset Management, LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Empery Asset Management, LP
13F Pro is an AI hedge fund tracker and stock research platform. For Empery Asset Management, LP (SEC CIK: 1469336), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Empery Asset Management, LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.